Valuation: Makers Laboratories Limited

Market Cap 1.07B 11.14M 9.89M 9.25M 8.43M 15.87M 16.09M 112M 43.31M 546M 41.81M 40.9M 1.75B P/E 2025
10.2x
P/E 2026 33.9x
Enterprise Value 1.02B 10.55M 9.37M 8.76M 7.98M 15.03M 15.24M 106M 41.03M 517M 39.6M 38.75M 1.66B EV / Sales 2025
0.67x
EV / Sales 2026 0.53x
Free-Float
31.45%
Yield 2025 *
-
Yield 2026 -

Last Transcript: Makers Laboratories Limited

1 day-2.02%
1 week-2.83%
Current month-2.02%
1 month-2.83%
3 months+21.91%
6 months+16.21%
Current year+53.79%
1 week 174.75
Extreme 174.75
188.4
1 month 171
Extreme 171
217.5
Current year 112.1
Extreme 112.1
236.55
1 year 109
Extreme 109
236.55
3 years 103.85
Extreme 103.85
236.55
5 years 94
Extreme 94
236.55
10 years 23.2
Extreme 23.2
344.8
Manager TitleAgeSince
Director of Finance/CFO 59 30/10/2017
Compliance Officer - 23/05/2024
Sales & Marketing 54 02/08/2017
Director TitleAgeSince
Director/Board Member 51 11/08/2011
Director/Board Member 52 29/01/2018
Chairman 77 28/03/2019
Change 5-day change 1-year change 3-year change Capi.($)
-2.02%-2.83%+33.11%+68.40% 11.41M
-0.62%-2.71%+39.30%+114.07% 1,031B
-2.30%-4.44%+39.03%+66.07% 638B
-0.63%-1.96%+6.36%+74.38% 462B
-1.03%-2.82%+59.56%+39.69% 359B
-0.03%-3.96%+23.63%+39.35% 335B
-1.58%-0.76%+13.50%+25.77% 273B
-2.02%-2.97%-3.25%+8.38% 253B
-3.38%+0.30%+36.44%+51.54% 228B
-1.04%-1.46%+32.70%+96.82% 185B
Average -1.47%-1.37%+28.04%+58.45% 376.39B
Weighted average by Cap. -1.25%-1.89%+30.52%+69.18%

Financials

2025 2026
Net sales 1.21B 12.54M 11.14M 10.42M 9.49M 17.87M 18.12M 126M 48.79M 615M 47.09M 46.07M 1.98B 1.41B 14.63M 13M 12.15M 11.07M 20.85M 21.14M 147M 56.92M 717M 54.93M 53.74M 2.3B
Net income 74.91M 778K 691K 646K 589K 1.11M 1.12M 7.82M 3.03M 38.15M 2.92M 2.86M 123M 23.51M 244K 217K 203K 185K 348K 353K 2.45M 950K 11.97M 917K 897K 38.46M
Net Debt 48.19M 501K 445K 416K 379K 713K 723K 5.03M 1.95M 24.54M 1.88M 1.84M 78.83M -56.5M -587K -521K -487K -444K -836K -848K -5.9M -2.28M -28.77M -2.2M -2.16M -92.42M
Logo Makers Laboratories Limited
Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. The Company's segments include Pharmaceutical and Chemical Manufacturing. It has one manufacturing unit in India manufacturing formulations for the Indian market. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimesulide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). It also offers a range of diabetic and hypertensive drugs, including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), and Hypernorm range (Telmisartan). Its product categories include Inspira - Retail Packs and Experia - Bulk Packs. Its Inspira - Retail Packs include anthelmintics, anti-biotics, anti-emetics and anti-nauseants. Its Experia - Bulk Packs include betamethasone 0.5 mg tablets, chloramphenicol capsules 250 mg and diclofenac 50 mg tablets.
Employees
114
Date Price Change Volume
01/10/26 ₹181.70 -2.02% 1,157
30/09/26 ₹185.45 -1.33% 285
29/09/26 ₹187.95 -0.16% 719
28/09/26 ₹188.25 0.00% 1,007
25/09/26 ₹188.25 +0.67% 170
  1. Stock Market
  2. Stocks
  3. MAKERSL Stock